Management of digoxin toxicity

Area of Science:

• Cardiology
• Clinical Pharmacology
• Toxicology

Background:

• Digoxin toxicity is a significant clinical concern, occurring with both therapeutic use and overdose.
• Symptoms range from gastrointestinal and neurological effects to life-threatening cardiac arrhythmias.
• Toxicity can manifest even with serum digoxin levels within the accepted therapeutic range.

Purpose of the Study:

• To review the indications, efficacy, and safety of digoxin-specific antibody fragments.
• To discuss the management of digoxin toxicity, including dosing considerations and post-treatment monitoring.
• To provide guidance on restarting digoxin therapy after toxicity.

Main Methods:

• Review of existing literature on digoxin toxicity and its treatment.
• Analysis of factors influencing the decision to use digoxin-specific antibody fragments.
• Discussion of clinical presentation, diagnosis, and management strategies.

Main Results:

• Digoxin-specific antibody fragments are indicated for severe digoxin toxicity.
• Dosing can be guided by ingested amount and serum concentration, but these are not always essential.
• These antibody fragments are safe and effective in managing severe toxicity.

Conclusions:

• Digoxin-specific antibody fragments are a valuable therapeutic option for severe digoxin toxicity.
• Post-treatment monitoring is crucial to detect potential rebound toxicity.
• Careful consideration of the original indication and reasons for toxicity is necessary before restarting digoxin therapy.